Item 9 Labs Corp.
INLBOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$70181
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Item 9 Labs Corp. (INLB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · INLB · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-09 | 2021-09 | 2020-09 | 2019-09 | 2018-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $21.76M | $21.94M | $8.12M | $4.93M | $1.38M |
| Cost of Revenue | $14.45M | $13.32M | $4.83M | $2.56M | $1.02M |
| Gross Profit | $7.31M | $8.61M | $3.30M | $2.38M | $0.36M |
| Gross Margin %(computed) | 33.61% | 39.26% | 40.58% | 48.19% | 25.97% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $17.02M | $9.89M | $5.52M | $4.12M | $0.39M |
| Total Operating Expenses | $30.38M | $14.21M | $8.62M | $6.76M | $1.05M |
| Operating Income | ($23.07M) | ($5.60M) | ($5.33M) | ($4.38M) | ($0.69M) |
| Operating Margin %(computed) | -106.01% | -25.53% | -65.58% | -88.82% | -50.28% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.07M | $0.03M |
| Interest Expense | $6.41M | $5.30M | $6.96M | $0.34M | $0.00M |
| Income Before Tax | ($31.17M) | ($10.91M) | ($12.39M) | ($9.95M) | ($0.66M) |
| Income Tax Expense | $0.01M | $0.00M | ($0.09M) | $0.68M | $0.03M |
| Net Income | ($31.14M) | ($10.91M) | ($12.30M) | ($10.63M) | ($0.64M) |
| Net Margin %(computed) | -143.14% | -49.71% | -151.44% | -215.47% | -46.70% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.33 | $-0.14 | $-0.20 | $-0.17 | $-0.23 |
| Wtd Avg Shares | 95.69M | 78.59M | 61.62M | 61.53M | 2.74M |
| EBITDA | ($22.83M) | ($4.35M) | ($4.45M) | ($8.93M) | ($0.60M) |
| EBITDA Margin %(computed) | -104.93% | -19.83% | -54.75% | -180.99% | -43.92% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Item 9 Labs Corp. data
About Item 9 Labs Corp. (INLB) Income Statement
Item 9 Labs Corp. (INLB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, INLB reported revenue of $0.02B, gross profit of $0.01B (gross margin 33.61%), and net income of ($0.03B) — a net profit margin of -143.14%.
Frequently asked questions
INLB · 4 questionsItem 9 Labs Corp. (INLB) reported revenue of $0.02B for 2022, down 0.8% year-over-year.
INLB revenueINLB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09